Xingquan Social Value Three-year Holding Period Hybrid Securities Investment Fund (abbreviation: Xingquan Social Value Three-year Holding Hybrid, code 008378) announced its latest net value on October 15, down 3.30%.
Founded on December 26, 2019, the performance comparison benchmark is the return of the CSI 300 Index ×60% + the yield of the Hang Seng Index (converted using the valuation exchange rate) ×20% + the yield of the China Bond Composite (Full Price) Index ×20%. The fund has returned 29.65% since its inception, 0.58% this year, 19.15% over the past month, -2.48% over the past year, and -26.96% over the last three years. In the past year, the fund ranked 4515/7516 in its peer group.
The fund manager is Xie Zhiyu. Xie Zhiyu has managed (or intends to manage) the fund since December 6, 2019, with a return of 29.65% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 01024 | Kuaishou-W | 8.00% | 2650990 | 112 million |
| 688008 | Montage Technology | 4.95% | 1216627 | 69.1172 million |
| 01415 | Gao Wei Electronics | 4.28% | 2670147 | 59.8281 million |
| 688099 | Jingchen shares | 4.09% | 963856 | 57.1759 million |
| 600703 | San'an Optoelectronics | 3.48% | 4150283 | 48.6413 million |
| 300750 | CATL | 3.44% | 266920 | 48.0536 million |
| 002273 | Crystal Optoelectronics | 3.04% | 2501069 | 42.4682 million |
| 01347 | Hua Hong Semiconductor | 2.99% | 2074449 | 41.7474 million |
| 01177 | China Biopharma | 2.96% | 16983000 | 41.3851 million |
| 06078 | Hygeia Medical | 2.92% | 1587412 | The 40,783,700 |
Ticker Name
Percentage Change
Inclusion Date
